Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pennsaid is a brand name for a topical formulation of diclofenac sodium, a nonsteroidal anti-inflammatory drug (NSAID). It is indicated for the treatment of pain and symptoms associated with osteoarthritis of the knee. The active ingredient, diclofenac sodium, works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), which are involved in the synthesis of prostaglandins—substances that mediate inflammation and pain. By reducing prostaglandin production at the site of application, Pennsaid provides localized relief from pain and inflammation without significant systemic absorption. The product is available as a clear or faintly colored solution intended for topical use only on the knees[1][2][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pennsaid (diclofenac).